OssDsign AB (publ.) announced that the company has reached the commercial milestone of 200 implants in France. Since entering the market in late 2019, OssDsign has signed several important tenders in France leading to significantly accelerated sales during the last year. In 2019, the French health authorities decided OssDsign Cranial PSI provided high therapeutic value to patients and granted the product reimbursement on the French market.

In early 2022, OssDsign decided to further increase focus on France and restructured its commercial presence accordingly, leading to solid sales acceleration in the second half of 2022 - ultimately allowing the company to reach the 200 implant milestone within only a few years. OssDsign Cranial PSI is a patient-specific cranial implant made from 3D printed medical-grade titanium covered by a regenerative calcium phosphate composition. While the titanium skeleton reinforces the implant and resists physical and mechanical stress, the unique calcium phosphate composition provides healing and regenerative properties, allowing regrowth of the patient's own bone.

Over time, the calcium phosphate composition degrades and is replaced with bone, leaving the patient with a well-integrated implant, potentially lasting a lifetime.